Systematic population-based identification of NTRK and RET fusion-positive thyroid cancers

OBJECTIVE: The aim of the study was to identify patients with NTRK fusion-positive or RET fusion/mutation-positive thyroid cancers, who could benefit from neurotrophic tyrosine kinase receptor (NTRK) or receptor tyrosine kinase (RET) inhibitors. METHODS: Patients were identified in the Calgary prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Eszlinger, Markus, Stewardson, Paul, McIntyre, John B, Box, Adrian, Khalil, Moosa, Hyrcza, Martin, Koro, Konstantin, Ruether, Dean, Wu, Jiahui, Paschke, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142806/
https://www.ncbi.nlm.nih.gov/pubmed/34981751
http://dx.doi.org/10.1530/ETJ-21-0061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142806/
https://www.ncbi.nlm.nih.gov/pubmed/34981751
http://dx.doi.org/10.1530/ETJ-21-0061

Ejemplares similares